Previous studies have demonstrated that polypeptide growth factor signal transduction pathways can stimulate AR activation, suggesting that the increase in growth factor and receptor expression could be causal in prostate cancer progression to castration resistance. The gene discussed is AR; the disease is prostate carcinoma.